Perfuze presents Millipede catheter data at SVIN26
Dr. Ameer E. Hassan compares Millipede 88 and 70 by M1 vessel diameter using MARRS data on November 20 at Resorts World Las Vegas.
See the latest news and media coverage for Perfuze. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical technology company developing stroke-treatment catheters
perfuze.comLast updated
Dr. Ameer E. Hassan compares Millipede 88 and 70 by M1 vessel diameter using MARRS data on November 20 at Resorts World Las Vegas.
Attendees can try the device at Booth 410, Resorts World Las Vegas, and view Dr. Demetrius Lopes' poster on the Zipline Access Catheter.
The 8F long sheath completes the company's stroke thrombectomy system and accommodates catheters up to 8F, designed for challenging anatomy such as a Type III aortic arch.
The presentations cover initial multicenter experience with the Zipline Access Catheter, a MARRS and SVIN Registry analysis, and Millipede88 versus Millipede70 by vessel diameter. The team is at Booth 410.
Perfuze's MARRS study met its primary endpoint, with successful reperfusion mTICI 2b-3 achieved in 89% of patients without rescue therapy.
Perfuze announced final results from its MARRS pivotal stroke trial on Friday. Eighty-nine percent of patients achieved successful reperfusion without needing rescue therapy, with a...
Medtech Perfuze has raised €22m. With the infusion, the company will release its catheters to select stroke centres in the US.
Galway-based Perfuze, a private medical device company dedicated to developing pioneering technology to treat acute ischemic stroke, announced US FDA clearance for the Millipede 070...
Track Perfuze and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.